Drug Profile
R 1671
Alternative Names: R1671; Roche 2Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Genmab; Roche
- Developer Roche
- Class Antiasthmatics; Monoclonal antibodies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Asthma in USA (IV, Infusion)
- 14 Nov 2006 Preclinical trials in Asthma in Europe (IV)